Skip to main content
GHK-Cu Script

Repair research and its supporting cast

Amounts and half-life in GHK-Cu studies

A concentration describes the material in an experiment. The difficult question is how much of that material reaches the place being studied.

GHK-Cu dosage in cell experiments

The collagen experiment in human fibroblast cultures found stimulation beginning between 10^-12 and 10^-11 M, with the maximum at 10^-9 M. M is molarity, a concentration in liquid. These figures describe what surrounded cells in a dish.

A tiny cell-culture number, in my judgement, loses much of its meaning when offered as a clue to a personal amount. The cells in that experiment were already accessible to the medium. A cream encounters skin; a systemic preparation encounters distribution and breakdown throughout a body. Those are further experiments, each needing its own measurements.

The published cell response also reached a maximum under the tested conditions. It supplies no rule that a larger amount produces a larger benefit. The question being tested matters most in my judgement; extracting a figure loses the question.

Topical concentrations and delivery

The human cream findings summarized in the skin-regeneration review concern topical formulations, including the 71-woman study over 12 weeks. The research summary records 0.1–1% GHK-Cu in the cream. Those concentrations belong to the reported study material; they establish no personal prescription.

The liposomal skin-permeation review asks a more troublesome question: how reliably can delivery through skin actually be measured? Plain aqueous GHK-Cu has limited passage through intact skin, and methods for assessing liposomal delivery remain insufficiently standardized. A liposome is a tiny lipid enclosure used to carry a substance.

I think delivery measurements deserve as much curiosity as the ingredient percentage. A sophisticated carrier can be an interesting research proposal while its actual performance in skin still requires careful measurement. The anti-wrinkle review makes the formulation problem central to the research, alongside the shortage of strong clinical comparisons.

A circular skin sample clamped inside a glass permeation cell
Illustration of an ex vivo skin-permeation setup. It depicts a type of laboratory arrangement, without identifying a particular experiment.

GHK-Cu half-life in humans

A validated human systemic half-life for GHK-Cu is absent from the published record summarized here. Half-life is the time a measured concentration takes to fall by half. The often-repeated timing estimates circulating with injection discussions lack the human pharmacokinetic measurements needed to support them.

The skin-delivery literature concerns a different setting. Skin permeation and carrier analysis cannot supply a reliable human injection interval. I want a measured concentration over time, with the tested form clearly identified, before putting faith in a timing claim.

Study duration and personal schedules

The skin-cream research described here generally ran for 8–12 weeks. That observation tells us the length of those topical experiments. Human systemic dose-finding and long-term safety studies would have to answer separate questions about exposure, benefit and harm.

Daily or cyclical use is sometimes presented as though the choice can be settled by borrowing a schedule from an animal model. The sources on these pages do not establish a human systemic regimen. A treatment decision requires a licensed health professional's assessment; this publication provides neither an amount to take nor a schedule to follow.